Browsing by 키워드 : NSCLC
전체 결과 12건 중 1-12 번을 표시중입니다.
- 1 Article Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial 이대호 ; Byoung Chul Cho ; Chia-Chi Lin ; et al 2020
- 2 Article Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic NSCLC : Initial Results of the Phase 2 ALK-Positive Cohort 이대호 ; Daniel S W Tan ; David S Shames ; et al 2021
- 3 Article Clinical Significance of Regional Lymph Node Evaluation During Sublobar Resection in Lung Cancer Jae Kwang Yun ; Geun Dong Lee ; Sehoon Choi ; et al 2022
- 4 Article Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations. 김상위 ; Agnieszka Cseh ; Christina Raabe ; et al 2021
- 5 Article Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC 고동인 ; 공지희 ; 기소영 ; et al 2020
- 6 Article Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non-Small Cell Lung Cancer Shinkyo Yoon ; Hannah Yang ; Hyun-Min Ryu ; et al 2022
- 7 Article Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non-small Cell Lung Cancer 이대호 ; Bo H Chao ; David Planchard ; et al 2021
- 8 Article Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC 김상위 ; Ajlan Atasoy ; Charuwan Akewanlop ; et al 2021
- 9 Article Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC Sang-We Kim ; Kye Young Lee ; Ajlan Atasoy ; et al 2022
- 10 Article Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis 김상위 ; Byoung Chul Cho ; Cheol Hyeon Kim ; et al 2020
- 11 Article Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea 최창민 ; Chan Kwon Park ; Cheol-Kyu Park ; et al 2021
-
12
Dissertation
근치적 방사선 치료 후 재발한 상피성장인자 수용체 돌연변이 비소세포폐암 환자에서 상피성장인자 수용체 티로신 키나아제 억제제의 효과
형재원
2019
1